Literature DB >> 18452394

Four USH2A founder mutations underlie the majority of Usher syndrome type 2 cases among non-Ashkenazi Jews.

Noa Auslender1, Dikla Bandah, Leah Rizel, Doron M Behar, Mordechai Shohat, Eyal Banin, Stavit Allon-Shalev, Reuven Sharony, Dror Sharon, Tamar Ben-Yosef.   

Abstract

Type 2 Usher syndrome (USH2) is a recessively inherited disorder, characterized by the combination of early onset, moderate-to-severe, sensorineural hearing loss, and vision impairment due to retinitis pigmentosa. From 74% to 90% of USH2 cases are caused by mutations of the USH2A gene. USH2A is composed of 72 exons, encoding for usherin, an extracellular matrix protein, which plays an important role in the development and maintenance of neurosensory cells in both retina and cochlea. To date, over 70 pathogenic mutations of USH2A have been reported in individuals of various ethnicities. Many of these mutations are rare private mutations segregating in single families. The aim of the current work was to investigate the genetic basis for USH2 among Jews of various origins. We found that four USH2A mutations (c.239-240insGTAC, c.1000C>T, c.2209C>T, and c.12067-2A>G) account for 64% of mutant alleles underlying USH2 in Jewish families of non-Ashkenazi descent. Considering the very large size of the USH2A gene and the high number of mutations detected in USH2 patients worldwide, our findings have significant implications for genetic counseling and carrier screening in various Jewish populations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452394     DOI: 10.1089/gte.2007.0107

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  12 in total

1.  Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa.

Authors:  Terri L McGee; Babak Jian Seyedahmadi; Meredith O Sweeney; Thaddeus P Dryja; Eliot L Berson
Journal:  J Med Genet       Date:  2010-05-27       Impact factor: 6.318

2.  Mutational screening of the USH2A gene in Spanish USH patients reveals 23 novel pathogenic mutations.

Authors:  Gema Garcia-Garcia; Maria J Aparisi; Teresa Jaijo; Regina Rodrigo; Ana M Leon; Almudena Avila-Fernandez; Fiona Blanco-Kelly; Sara Bernal; Rafael Navarro; Manuel Diaz-Llopis; Montserrat Baiget; Carmen Ayuso; Jose M Millan; Elena Aller
Journal:  Orphanet J Rare Dis       Date:  2011-10-17       Impact factor: 4.123

3.  The many faces of sensorineural hearing loss: one founder and two novel mutations affecting one family of mixed Jewish ancestry.

Authors:  Doron M Behar; Bella Davidov; Zippora Brownstein; Tamar Ben-Yosef; Karen B Avraham; Mordechai Shohat
Journal:  Genet Test Mol Biomarkers       Date:  2013-12-24

4.  The USH2A c.2299delG mutation: dating its common origin in a Southern European population.

Authors:  Elena Aller; Lise Larrieu; Teresa Jaijo; David Baux; Carmen Espinós; Fernando González-Candelas; Carmen Nájera; Francesc Palau; Mireille Claustres; Anne-Françoise Roux; José M Millán
Journal:  Eur J Hum Genet       Date:  2010-02-10       Impact factor: 4.246

5.  Novel mutations of MYO7A and USH1G in Israeli Arab families with Usher syndrome type 1.

Authors:  Leah Rizel; Christine Safieh; Stavit A Shalev; Eedy Mezer; Haneen Jabaly-Habib; Ziva Ben-Neriah; Elena Chervinsky; Daniel Briscoe; Tamar Ben-Yosef
Journal:  Mol Vis       Date:  2011-12-30       Impact factor: 2.367

6.  MYO7A and USH2A gene sequence variants in Italian patients with Usher syndrome.

Authors:  Andrea Sodi; Alessandro Mariottini; Ilaria Passerini; Vittoria Murro; Iryna Tachyla; Benedetta Bianchi; Ugo Menchini; Francesca Torricelli
Journal:  Mol Vis       Date:  2014-12-23       Impact factor: 2.367

7.  Next-generation sequencing reveals the mutational landscape of clinically diagnosed Usher syndrome: copy number variations, phenocopies, a predominant target for translational read-through, and PEX26 mutated in Heimler syndrome.

Authors:  Christine Neuhaus; Tobias Eisenberger; Christian Decker; Sandra Nagl; Cornelia Blank; Markus Pfister; Ingo Kennerknecht; Cornelie Müller-Hofstede; Peter Charbel Issa; Raoul Heller; Bodo Beck; Klaus Rüther; Diana Mitter; Klaus Rohrschneider; Ute Steinhauer; Heike M Korbmacher; Dagmar Huhle; Solaf M Elsayed; Hesham M Taha; Shahid M Baig; Heidi Stöhr; Markus Preising; Susanne Markus; Fabian Moeller; Birgit Lorenz; Kerstin Nagel-Wolfrum; Arif O Khan; Hanno J Bolz
Journal:  Mol Genet Genomic Med       Date:  2017-07-06       Impact factor: 2.183

8.  USH2A gene variants cause Keratoconus and Usher syndrome phenotypes in Pakistani families.

Authors:  Asif Naveed Ahmed; Raheel Tahir; Niamat Khan; Mushtaq Ahmad; Muhammad Dawood; Abdul Basit; Muhammad Yasin; Maha Nowshid; Muhammad Marwan; Komal Sultan; Shamim Saleha
Journal:  BMC Ophthalmol       Date:  2021-04-29       Impact factor: 2.209

9.  Spectrum of genes for inherited hearing loss in the Israeli Jewish population, including the novel human deafness gene ATOH1.

Authors:  Zippora Brownstein; Suleyman Gulsuner; Tom Walsh; Fábio T A Martins; Shahar Taiber; Ofer Isakov; Ming K Lee; Mor Bordeynik-Cohen; Maria Birkan; Weise Chang; Silvia Casadei; Nada Danial-Farran; Amal Abu-Rayyan; Ryan Carlson; Lara Kamal; Asgeir Ö Arnthórsson; Meirav Sokolov; Dror Gilony; Noga Lipschitz; Moshe Frydman; Bella Davidov; Michal Macarov; Michal Sagi; Chana Vinkler; Hana Poran; Reuven Sharony; Nadra Samra; Na'ama Zvi; Hagit Baris-Feldman; Amihood Singer; Ophir Handzel; Ronna Hertzano; Doaa Ali-Naffaa; Noa Ruhrman-Shahar; Ory Madgar; Efrat Sofrin-Drucker; Amir Peleg; Morad Khayat; Mordechai Shohat; Lina Basel-Salmon; Elon Pras; Dorit Lev; Michael Wolf; Eirikur Steingrimsson; Noam Shomron; Matthew W Kelley; Moien N Kanaan; Stavit Allon-Shalev; Mary-Claire King; Karen B Avraham
Journal:  Clin Genet       Date:  2020-08-24       Impact factor: 4.296

10.  Improving the management of Inherited Retinal Dystrophies by targeted sequencing of a population-specific gene panel.

Authors:  Nereida Bravo-Gil; Cristina Méndez-Vidal; Laura Romero-Pérez; María González-del Pozo; Enrique Rodríguez-de la Rúa; Joaquín Dopazo; Salud Borrego; Guillermo Antiñolo
Journal:  Sci Rep       Date:  2016-04-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.